Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Prognostic role of pretreatment derived neutrophil to lymphocyte ratio in urological cancers: A systematic review and meta-analysis.

Su S, Liu L, Li C, Zhang J, Li S.

Int J Surg. 2019 Dec;72:146-153. doi: 10.1016/j.ijsu.2019.10.043. Epub 2019 Nov 9. Review.

PMID:
31707011
3.

Prognostic role of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in prostate cancer: A meta-analysis of results from multivariate analysis.

Guo J, Fang J, Huang X, Liu Y, Yuan Y, Zhang X, Zou C, Xiao K, Wang J.

Int J Surg. 2018 Dec;60:216-223. doi: 10.1016/j.ijsu.2018.11.020. Epub 2018 Nov 20.

PMID:
30468905
4.

The Prognostic Value of Pretreatment Plasma Fibrinogen in Urological Cancers: A Systematic Review and Meta-analysis.

Song H, Kuang G, Zhang Z, Ma B, Jin J, Zhang Q.

J Cancer. 2019 Jan 1;10(2):479-487. doi: 10.7150/jca.26989. eCollection 2019.

5.

Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis.

Su L, Zhang M, Zhang W, Cai C, Hong J.

Medicine (Baltimore). 2017 Mar;96(11):e6364. doi: 10.1097/MD.0000000000006364. Review.

6.

Prognostic significance of peripheral blood-derived neutrophil/lymphocyte ratio in patients with digestive cancer.

Liu F, Luo H, Zhu Z, Zhu P, Huang J.

J Cell Physiol. 2019 Dec;234(12):22775-22786. doi: 10.1002/jcp.28842. Epub 2019 May 29.

PMID:
31140613
7.

Pre-treatment prognostic nutritional index may serve as a potential biomarker in urinary cancers: a systematic review and meta-analysis.

Qi F, Zhou X, Wang Y, Wang Y, Wang Y, Zhang Q, Cong R, Yang J, Song N.

Cancer Cell Int. 2018 Dec 17;18:207. doi: 10.1186/s12935-018-0708-7. eCollection 2018.

8.

Prognostic significance of elevated pretreatment systemic inflammatory markers for patients with prostate cancer: a meta-analysis.

Peng H, Luo X.

Cancer Cell Int. 2019 Mar 25;19:70. doi: 10.1186/s12935-019-0785-2. eCollection 2019.

9.

Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.

Dalpiaz O, Pichler M, Mannweiler S, Martín Hernández JM, Stojakovic T, Pummer K, Zigeuner R, Hutterer GC.

Br J Cancer. 2014 May 13;110(10):2531-6. doi: 10.1038/bjc.2014.180. Epub 2014 Apr 1.

10.

Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model.

Deng Q, He B, Liu X, Yue J, Ying H, Pan Y, Sun H, Chen J, Wang F, Gao T, Zhang L, Wang S.

J Transl Med. 2015 Feb 18;13:66. doi: 10.1186/s12967-015-0409-0.

11.

Prognostic Significance of Pretreatment Apolipoprotein A-I as a Noninvasive Biomarker in Cancer Survivors: A Meta-Analysis.

Zhang Y, Yang X.

Dis Markers. 2018 Oct 30;2018:1034037. doi: 10.1155/2018/1034037. eCollection 2018. Review.

12.
13.

Prognostic role of pretreatment neutrophil-to-lymphocyte ratio in non-small cell lung cancer patients treated with systemic therapy: a meta-analysis.

Wang Z, Zhan P, Lv Y, Shen K, Wei Y, Liu H, Song Y.

Transl Lung Cancer Res. 2019 Jun;8(3):214-226. doi: 10.21037/tlcr.2019.06.10.

14.

Prognostic role of derived neutrophil-to-lymphocyte ratio in surgical triple-negative breast cancer.

Ren K, Yin Y, He F, Shao Y, Wang S.

Cancer Manag Res. 2018 Oct 24;10:4891-4898. doi: 10.2147/CMAR.S180695. eCollection 2018.

15.

Systematic review and meta-analysis of the prognostic value of preoperative platelet-to-lymphocyte ratio in patients with urothelial carcinoma.

Wu S, Wan Q, Xu R, Zhu X, He H, Zhao X.

Oncotarget. 2017 Sep 22;8(53):91694-91702. doi: 10.18632/oncotarget.21162. eCollection 2017 Oct 31.

16.

Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma.

Wang Z, Peng S, Wang A, Xie H, Guo L, Jiang N, Niu Y.

Clin Chim Acta. 2018 May;480:166-172. doi: 10.1016/j.cca.2018.02.014. Epub 2018 Feb 17.

PMID:
29462592
17.

Prognostic value of aspartate transaminase to alanine transaminase (De Ritis) ratio in solid tumors: a pooled analysis of 9,400 patients.

Wu J, Chen L, Wang Y, Tan W, Huang Z.

Onco Targets Ther. 2019 Jul 2;12:5201-5213. doi: 10.2147/OTT.S204403. eCollection 2019.

18.

Prognostic significance of platelet-to-lymphocyte ratio in urothelial carcinoma patients: a meta-analysis.

Bao Y, Wang Y, Li X, Pan M, Zhang H, Cheng Z, Wang X.

Cancer Cell Int. 2019 Nov 27;19:315. doi: 10.1186/s12935-019-1032-6. eCollection 2019.

19.

Cancer stem cell markers predict a poor prognosis in renal cell carcinoma: a meta-analysis.

Cheng B, Yang G, Jiang R, Cheng Y, Yang H, Pei L, Qiu X.

Oncotarget. 2016 Oct 4;7(40):65862-65875. doi: 10.18632/oncotarget.11672.

20.

Supplemental Content

Support Center